SolGel Technologies (SLGL) appears to have found support after losing some value lately, as indicate

Last patient has completed the last scheduled study visit in the pivotal Phase 3 clinical trial of S

Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(1.13) per share which beat the ana

NESS ZIONA, Israel, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a d

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Sol-Gel Technologies (NASDAQ:SLGL)

Wall Street analysts upgraded various top stocks, including Nucor, Varonis, Invitation Homes, and Ma

Wall Street analysts changed outlook on top names, see all changes on Benzinga's analyst ratings

Mizuho analyst Uy Ear initiates coverage on Sol-Gel Technologies (NASDAQ:SLGL) with a Outperform

Sol-Gel Technologies Ltd. (SLGL) came out with a quarterly loss of $1.31 per share versus the Zacks

Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(1.31) per share which beat the ana

Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property pr

NESS ZIONA, Israel, March 23, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (the “Company”) (NA

Sol-Gel Technologies Ltd. (SLGL) came out with a quarterly loss of $1.07 per share versus the Zacks

NESS ZIONA, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), an

Sol-Gel Technologies (NASDAQ: SLGL - Get Free Report) and Assembly Biosciences (NASDAQ: ASMB - Get F

Sol-Gel Technologies Ltd. (NASDAQ: SLGL - Get Free Report) major shareholder Opaleye Management Inc.

Sol-Gel Technologies Ltd. (NASDAQ: SLGL - Get Free Report) major shareholder Opaleye Management Inc.

Sol-Gel Technologies Ltd. (NASDAQ: SLGL - Get Free Report) major shareholder Opaleye Management Inc.

Sol-Gel Technologies ends development of SGT-210 in Darier disease after Phase 1b data show no effic

Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate

Patient enrollment for our ongoing Phase-3 clinical trial of SGT-610 for Gorlin Syndrome has been co

NESS ZIONA, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a cl

NESS ZIONA, Israel, May 01, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (the “Company”) (NASD

Sol-Gel to receive $16 million during 2025 Cash runway is expected to extend into the first quarter

This detailed market intelligence publication offers valuable insights into the innovative technolog

Sol-Gel's fourth-quarter 2024 earnings are likely to have gained from higher licensing revenues from

  On Thursday, 369 companies hit new 52-week lows.

  On Wednesday, 311 stocks hit new 52-week lows.

  On Tuesday, 647 companies set new 52-week lows.

  Friday's session saw 112 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  On Tuesday, 386 stocks made new 52-week lows.

  Friday's session saw 169 companies set new 52-week lows.

Upgrades

  On Thursday, 588 stocks hit new 52-week lows.

  On Wednesday, 329 companies hit new 52-week lows.

  Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earning

Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Mo

This morning 279 companies reached new 52-week highs.

    On Monday morning, 415 companies achieved new highs for the year.

    Before 10 a.m. ET on Friday, 571 companies hit new 52-week highs.